U.S. Department of Health and Human Services - U.S. Food and Drug Administration Forms
The U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) are responsible for ensuring the safety and effectiveness of foods, drugs, vaccines, medical devices, cosmetics, and other products related to public health. They protect and promote the health of the American public by regulating and overseeing the manufacturing, marketing, and distribution of these products. The FDA sets standards, conducts inspections, approves products, and provides information to the public about the safe use of these products. They also regulate clinical trials and monitor the safety of products on the market.
Documents:
54
This document serves as a comprehensive guide providing information about the different types of birth control methods available, their effectiveness, and potential risks and benefits. It is designed to educate individuals on making informed decisions about contraception.
PDF 
Word
This document evaluates studies on the connection between artificial food colors and behavior disorders in children. It summarizes the findings and provides insights into the potential impact of these colors on children's behavior.
This form is used for submitting advertisements and promotional labeling materials for drugs and biologics intended for human use to the Food and Drug Administration (FDA). It helps ensure that these materials meet the regulatory requirements for safety and effectiveness.
This form is used for summarizing the bacteriological results obtained from testing food samples. It is typically required by the FDA for regulatory purposes.
This form is used for reporting the analysis of a sample to the Food and Drug Administration (FDA). It is used to provide information about the composition and quality of the sample.
This Form is used for providing additional information or continuation of data for FDA applications and reports.
This form is used for reporting the analysis of a sample to the Food and Drug Administration (FDA). It provides important information about the analysis and helps ensure compliance with FDA regulations.
This form is used for recording bacteriological data related to shellfish in order to comply with FDA regulations.
This form is used for submitting additional information and details related to a botulism case to the Food and Drug Administration (FDA).
This form is used for reporting the quantity of contents for a product regulated by the US Food and Drug Administration (FDA).
This form is used for tracking and recording samples in the food and drug industry. It helps maintain accountability and ensure proper handling and storage of samples.
This form is used for summarizing the samples submitted to the U.S. Food and Drug Administration (FDA). It helps track and document the information related to the samples, including their source, testing methods, and results.
This Form is used for requesting Fsvp records from the FDA.
This document is a form used by the FDA to report observations related to the Foreign Supplier Verification Program (FSVP). It helps document any non-compliant practices or violations found during inspections of imported food products.
This type of document, FDA Form 1571, is used for submitting an Investigational New Drug Application (IND). It is required by the U.S. Food and Drug Administration (FDA) when seeking approval to conduct clinical trials of a new drug.
This Form is used for submitting information related to the use of aluminum in parenteral nutrition solutions. It is being reviewed by the Office of Management and Budget and public comments are requested.
This document provides guidelines and tips on how to reduce the risk of microbial food safety hazards for fresh fruits and vegetables. It offers recommendations on handling, storage, and preparation to ensure the safety of these food items.
This form is used for applying to market a new or abbreviated new drug or biologic for human use.
This form is used for the certificate and transmittal of an application to the FDA.
This form is used for reporting the results of tuberculin tests conducted on cattle.
This document provides information about the Paragard T380A intrauterine copper contraceptive. It includes details about how it works and its effectiveness as a birth control method.
This document is a Preliminary Finding of No Significant Impact (FONSI) for Aquadvantage Salmon. It provides an assessment of the environmental impact of Aquadvantage Salmon and concludes that it does not have a significant negative impact on the environment.
This document is for individuals who want to learn more about their state's Vocational Rehabilitation Agency. It provides information on the agency's services and programs, which are designed to help individuals with disabilities prepare for, find, and maintain employment.
This form is used for the early food safety evaluation of a new non-pesticidal protein produced by a new plant variety. It is required for the consultation on a new protein before it can be deemed safe for consumption.
This document provides insights into the priorities, initiatives, and innovation of the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA). It features a speech by Janet Woodcock, MD, the Director of CDER, shedding light on the organization's goals and strategies.
This document provides a self-assessment tool for importers and filers in the food industry to evaluate their food defense measures and ensure the safety and security of imported food products. It helps to identify potential vulnerabilities and implement necessary controls.
This document provides guidance and answers frequently asked questions regarding the Statement of Investigator (Form FDA 1572). It is a form used by sponsors, clinical investigators, and IRBs for medical research purposes.
This document provides guidance and answers frequently asked questions for sponsors, clinical investigators, and IRBs regarding the Statement of Investigator (Form FDA 1572). The form is used for collecting essential information about the clinical investigator participating in a clinical trial.
